Ajanta Pharma Limited on July 30, 2026, declared a select dividend of ₹32 per equity share following its board meeting that also approved financial results for the quarter ended June 30, 2026. The announcement was made to the NSE at 14:42 IST, making it one of the higher per-share payouts in the company's recent dividend history.

Dividend Details

Dividend Yield Context

Since the quote and trade data were unavailable at the time of this report, a precise dividend yield calculation against the current market price cannot be provided. Investors should compute yield as (₹32 divided by the prevailing market price) multiplied by 100. For reference, at a hypothetical price of ₹2,800 per share, the yield would stand at approximately 1.14%, and at ₹2,400 it would be approximately 1.33%. Investors are advised to verify the current traded price on NSE before arriving at an accurate yield figure.

Historical Dividend Trend

Ajanta Pharma's dividend track record over the past four years reflects a consistent upward trajectory in per-share payouts:

The data shows a compound growth of approximately 46% in per-share dividend from the ₹7 level in November 2022 to the current ₹32, indicating management's growing confidence in distributable cash flows over the period.

Company and Sector Background

Ajanta Pharma Limited (NSE: AJANTPHARM, ISIN: INE031B01015) is a specialty pharmaceutical company with operations spanning branded generics in India, Africa, and Asia. The company's Q1 FY27 financial results were simultaneously filed with the exchange, providing the earnings basis on which the board made this dividend decision. Pharmaceutical sector companies in India have generally maintained dividend yields in the range of 0.5% to 1.5%, and Ajanta's consistent payout growth places it among the more shareholder-return-focused mid-cap pharma names.

What This Means for Investors

The shift from an interim dividend classification to a select dividend in the July 2026 announcement is notable, as it suggests the board is treating this as a deliberate, results-linked distribution rather than a routine interim payout. The ₹32 figure represents a 14.3% increase over the most recent prior payout of ₹28 declared in November 2025. Record date and payment date details had not been disclosed in the exchange filing at the time of publication. Investors holding Ajanta Pharma shares should monitor NSE announcements for the record date to confirm eligibility for this dividend.